Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

H+/K+-ATPase inhibitors and their use described by AstraZeneca researchers

April 2, 2003

Novel gastric antisecretory drugs under study at Altana Pharma

March 27, 2003

Helicide approved in Canada for H. pylori eradication

March 20, 2003

Novel viral polymerase inhibitors identified at Boehringer Ingelheim

March 17, 2003

Enanta earns milestone in Chiron hepatitis C collaboration

March 14, 2003

Gilead's Hepsera approved for marketing in E.U. countries

March 12, 2003

New data on adefovir dipivoxil in the long-term treatment of chronic hepatitis B

March 7, 2003

Boehringer Ingelheim prepares and tests series of HCV NS5B inhibitors

March 6, 2003

ANA-245 completes phase IA clinical testing

March 5, 2003

Novel anti-HCV NS3 protease agents presented by Vertex

March 3, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...